Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2031

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2031

Induced Pluripotent Stem Cell (IPSC) Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cell (iPSC) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:

Where is the largest and fastest growing market for induced pluripotent stem cell (iPSC)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The induced pluripotent stem cell (iPSC) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider induced pluripotent stem cell (iPSC) market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the induced pluripotent stem cell (iPSC) market.

Key Trends - Highlights the major trends shaping the global induced pluripotent stem cell (iPSC) market. This section also highlights likely future developments in the market.

Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional And Country Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region and country.

Market Segmentation - Contains the market values (2016-2031) and analysis for for segment by derived cell type, by application, and by end-user in the market.

Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

Conclusions And Recommendations - Includes recommendations for induced pluripotent stem cell (IPSC) providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

Appendix

This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Derived Cell Type: Blood Cells; Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Others

2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell & Gene Therapy

3) By End-User: Hospitals; Research Laboratories

Companies Mentioned: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc); Thermo Fisher Scientific, Inc.; Takara Bio, Inc.; Lonza Group AG; Astellas Pharma Inc.

Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; induced pluripotent stem cell (iPSC) indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Induced Pluripotent Stem Cell (iPSC) Market Definition and Segmentations
6.4. Market Segmentation By Derived Cell Type
6.4.1. Blood Cells
6.4.2. Hepatocytes
6.4.3. Fibroblasts
6.4.4. Keratinocytes
6.4.5. Amniotic
6.4.6. Others
6.5. Market Segmentation By Application
6.5.1. Academic Research
6.5.2. Drug Discovery And Toxicity Studies
6.5.3. Regenerative Medicine
6.5.4. Gene & Cell Therapy
6.6. Market Segmentation By End-User
6.6.1. Hospitals
6.6.2. Research Laboratories
7. Major Market Trends
7.1. Use of Pluripotent Stem Cells in treating Parkinson’s Disease (PD)
7.2. Strategic Collaborations And Partnerships
7.3. Development Of Induced Pluripotent Stem Cell iPSC-Derived NK Cells
7.4. Demand For Induced Pluripotent Stem Cell (iPSC) For Cell Therapy
7.5. Investment In Regenerative Medicine Research And Development
7.6. Advancements In Technology Transfer And Clinical Translation
7.7. Use of Pluripotent Stem Cells in treating Type 1 Diabetes
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2016 – 2021, Value ($ Million)
8.2.1. Market Drivers 2016 – 2021
8.2.2. Market Restraints 2016 – 2021
8.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
8.3.1. Market Drivers 2021 – 2026
8.3.2. Market Restraints 2021 – 2026
9. Global Market Segmentation
9.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
9.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
9.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
10. Global Market, Regional And Country Analysis
10.1. Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
10.2. Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.4. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.5. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.6. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.7. Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
11.8. China Market
11.9. Summary
11.10. Market Overview
11.10.1. Country Information
11.10.2. Market Information
11.10.3. Background Information
11.10.4. Government Initiatives
11.10.5. Regulations
11.10.6. Regulatory Bodies
11.10.7. Major Associations
11.10.8. Taxes Levied
11.10.9. Corporate Tax Structure
11.10.10. Investments
11.10.11. Major Companies
11.11. China Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.12. China Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.13. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.14. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.15. India Market
11.16. India Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.17. India Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.18. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.19. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.20. Japan Market
11.21. Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.22. Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.23. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.24. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.25. Australia Market
11.26. Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.27. Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.28. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.29. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.30. Indonesia Market
11.31. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.32. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.33. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.34. South Korea Market
11.35. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.36. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.37. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.38. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.4. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.5. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
12.8. UK Market
12.9. UK Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.10. UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.11. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.12. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.13. Germany Market
12.14. Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.15. Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.16. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.17. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.18. France Market
12.19. France Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.20. France Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.21. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.22. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes levied
13.2.9. Corporate tax structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.4. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.5. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
13.8. Russia Market
13.9. Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.10. Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.11. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.12. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes levied
14.2.9. Corporate tax structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.4. North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.5. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.6. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.7. North America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
14.8. USA Market
14.9. Summary
14.10. Market Overview
14.10.1. Country Information
14.10.2. Market Information
14.10.3. Background Information
14.10.4. Government Initiatives
14.10.5. Regulations
14.10.6. Regulatory Bodies
14.10.7. Associations
14.10.8. Taxes Levied
14.10.9. Corporate Tax Structure
14.10.10. Investments
14.10.11. Major Companies
14.11. USA Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.12. USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.13. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.14. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
15.4. South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
15.5. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.6. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.7. South America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
15.8. Brazil Market
15.9. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
15.10. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
15.11. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.12. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory bodies
16.2.7. Major Associations
16.2.8. Taxes levied
16.2.9. Corporate tax structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
16.4. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
16.5. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory bodies
17.2.7. Major Associations
17.2.8. Taxes levied
17.2.9. Corporate tax structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
17.4. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17.5. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape And Company Profiles
19. Company Profiles
19.1. FUJIFILM Holdings Corporation
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. Thermo Fisher Scientific, Inc
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. Takara Bio, Inc
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. Lonza Group AG
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. Astellas Pharma Inc
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Business Strategy
19.5.4. Financial Overview
20. Key Mergers and Acquisitions
20.1. Vertex Pharmaceuticals Acquired ViaCyte
20.2. Medipost Acquired OmniaBio
20.3. Catalent Acquired RheinCell Therapeutics
20.4. Selvita Acquired Fidelta from Galapagos
20.5. Bayer Acquired Asklepios BioPharmaceutical (AskBio)
20.6. Boehringer Ingelheim Acquired Global Stem Cell Technology (GST)
20.7. Vertex Pharmaceuticals Acquired Semma Therapeutics
21. Opportunities And Strategies
21.1. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 – Countries Offering Most New Opportunities
21.2. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 – Segments Offering Most New Opportunities
21.3. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Biotechnology Services Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. The Business Research Company
23.5. Copyright and Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings